Healio offers a video report by Jeffrey T. Kuvin, MD FACC on the ASCEND trial of aspirin and omega-3 fatty acids for primary cardiovascular prevention in patients with diabetes. According to Kuvin who leads the cardiovascular medicine at the Heart and Vascular Center at Dartmouth-Hitchcock Medical Center, the study has produced “mixed messages” as Healio noted this interview was provided to Cardiology Today.

Source: Healio

Pin It on Pinterest